Epirubicin: bladder perforation (first report) with extravasation, cellulitis, fibrosis, necrosis and inflammation following intravesical administration in elderly patients: 2 case report

Citation metadata

Date: Aug. 28, 2010
From: Reactions Weekly(Issue 1316)
Publisher: Wolters Kluwer Health, Inc.
Document Type: Case study
Length: 410 words
Lexile Measure: 1100L

Document controls

Main content

Article Preview :

[*] [S]

Bladder perforation with extravasation, cellulitis, fibrosis, necrosis and inflammation occurred in two elderly men after intravesical instillation of epirubicin for bladder cancer.

An 82-year-old man underwent transurethral resection of a bladder tumour and received two epirubicin 50mL instillations within 24 and 48 hours of surgery; the catheter was clamped to hold the agent in the bladder. Instillations were well tolerated for 2 hours. He became febrile and reported abdominal fullness and malaise 24 hours after the second instillation. Retropubic cellulitis was evident, and he immediately received IV fluids and broad-spectrum antibiotics. CT with retrograde cystogram and ultrasound identified bladder perforation with...

Source Citation

Source Citation   

Gale Document Number: GALE|A249605324